Lorazepam and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Pataday (olopatadine hydrochloride). Common drug interactions include abdominal pain upper among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Pataday. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

On Jul, 26, 2026

100 people who take Lorazepam and Pataday together, and have interactions are studied.

Lorazepam and Pataday drug interactions.

What are the common drug interactions of Lorazepam and Pataday, by gender? *:

female:

Abdominal pain upper
Akathisia (a movement disorder characterized by a feeling of inner restlessness)
Alanine aminotransferase increased
Anaphylactic reaction (serious allergic reaction)
Anorectal discomfort
Aspartate aminotransferase increased
Asthenia (weakness)
Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
Balance disorder
Bladder disorder

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)
Anaemia (lack of blood)
Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)

What are the common drug interactions of Lorazepam and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Depressed mood
Irritability
Malaise (a feeling of general discomfort or uneasiness)
Pain
Weight increased
Weight loss poor

40-49:

Abdominal pain
Cough
Hypersensitivity
Asthma
Chronic kidney disease
Depression
Emotional distress
Fatigue (feeling of tiredness)
Hip fracture
Osteopenia (a condition where bone mineral density is lower than normal)

50-59:

Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Headache (pain in head)
Hip fracture
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Infusion related reaction
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Pain in extremity
Rash

60+:

Chronic kidney disease
Renal failure (kidney dysfunction)
Menstrual disorder (disease of menstrual cycle)
Neck pain
Nephrolithiasis (calculi in the kidneys)
Oedema (fluid collection in tissue)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Productive cough

What are the existing conditions these people have? *

Pain: 24 people, 24.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 23 people, 23.00%
Nausea (feeling of having an urge to vomit): 20 people, 20.00%
Depression: 19 people, 19.00%
Asthma: 17 people, 17.00%
Hypersensitivity: 17 people, 17.00%
High Blood Cholesterol: 15 people, 15.00%
Migraine (headache): 15 people, 15.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 14.00%
Insomnia (sleeplessness): 12 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously